[{"address1": "25 North 38th Street", "address2": "11th Floor", "city": "Philadelphia", "state": "PA", "zip": "19104", "country": "United States", "phone": "267 817 5790", "website": "https://www.centurytx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY-308, a CD19-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 demonstrating preclinical efficacy comparable to autologous CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases and malignancies; and CNTY-341, A CD19/CD22 dual-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 which pairs dual targeting and primary T-cell-like functionality in an allogeneic cell with the goal of providing a differentiated therapy for B cell malignancies that are in preclinical trial. In addition, it develops solid tumor CAR iT program exploiting Nectin-4 CAR and other validated targets, engineered with Allo-Evasion 5.0 and additional engineering aimed at overcoming the key barriers to success in solid tumors, as well as non-immune effector. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Ms. Megan  Bilson", "title": "Chief People Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Michael  Naso Ph.D.", "title": "Senior VP of Cell Engineering", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Devlin", "title": "VP & Head of Development", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.77, "open": 1.79, "dayLow": 1.74, "dayHigh": 1.95, "regularMarketPreviousClose": 1.77, "regularMarketOpen": 1.79, "regularMarketDayLow": 1.74, "regularMarketDayHigh": 1.95, "payoutRatio": 0.0, "beta": 1.725, "forwardPE": -1.5772358, "volume": 2326036, "regularMarketVolume": 2326036, "averageVolume": 1662698, "averageVolume10days": 3458740, "averageDailyVolume10Day": 3458740, "bid": 0.4789, "ask": 0.8299, "bidSize": 2, "askSize": 2, "marketCap": 169566304, "fiftyTwoWeekLow": 0.342, "fiftyTwoWeekHigh": 1.95, "allTimeHigh": 32.899, "allTimeLow": 0.342, "priceToSalesTrailing12Months": 1.4961249, "fiftyDayAverage": 0.68758, "twoHundredDayAverage": 0.577055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 81583760, "profitMargins": -0.23366, "floatShares": 47142337, "sharesOutstanding": 87405311, "sharesShort": 246333, "sharesShortPriorMonth": 497543, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0028, "heldPercentInsiders": 0.25474, "heldPercentInstitutions": 0.38583001, "shortRatio": 0.27, "shortPercentOfFloat": 0.004, "impliedSharesOutstanding": 87405311, "bookValue": 2.038, "priceToBook": 0.9519136, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -26482000, "trailingEps": -0.32, "forwardEps": -1.23, "enterpriseToRevenue": 0.72, "enterpriseToEbitda": -8.322, "52WeekChange": 0.8247423, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 1.94, "targetHighPrice": 6.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.0, "targetMedianPrice": 2.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 132749000, "totalCashPerShare": 1.52, "ebitda": -9803000, "totalDebt": 44957000, "quickRatio": 6.049, "currentRatio": 6.252, "totalRevenue": 113337000, "debtToEquity": 25.493, "revenuePerShare": 1.317, "returnOnAssets": -0.044749998, "returnOnEquity": -0.14236, "grossProfits": 7990000, "freeCashflow": 10888000, "operatingCashflow": -112022000, "grossMargins": 0.0705, "ebitdaMargins": -0.086490005, "operatingMargins": -0.20004, "financialCurrency": "USD", "symbol": "IPSC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624023000000, "postMarketChangePercent": 1.5463902, "postMarketPrice": 1.97, "postMarketChange": 0.029999971, "regularMarketChange": 0.17, "regularMarketDayRange": "1.74 - 1.95", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1662698, "fiftyTwoWeekLowChange": 1.598, "fiftyTwoWeekLowChangePercent": 4.6725144, "fiftyTwoWeekRange": "0.342 - 1.95", "fiftyTwoWeekHighChange": -0.00999999, "fiftyTwoWeekHighChangePercent": -0.0051282, "fiftyTwoWeekChangePercent": 82.47423, "earningsTimestamp": 1763040600, "earningsTimestampStart": 1763040600, "earningsTimestampEnd": 1763040600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.32, "epsForward": -1.23, "epsCurrentYear": -0.2, "priceEpsCurrentYear": -9.7, "fiftyDayAverageChange": 1.2524201, "fiftyDayAverageChangePercent": 1.8214899, "twoHundredDayAverageChange": 1.3629451, "twoHundredDayAverageChangePercent": 2.3618982, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 9.60452, "regularMarketPrice": 1.94, "shortName": "Century Therapeutics, Inc.", "longName": "Century Therapeutics, Inc.", "marketState": "CLOSED", "ipoExpectedDate": "2021-06-18", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1768006746, "regularMarketTime": 1767992401, "exchange": "NCM", "messageBoardId": "finmb_626518430", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Century Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]